KPTI

Karyopharm Therapeutics Inc. NMS · KPTI

$9.51 +0.13 (+1.39%)

Neutral · -0.26σ

+ Compare Open in Sniper

Valuation

Market cap $0.2B

P/E (ttm) —

Forward P/E -1.9

Beta (5y) 0.81

Shares out 22.7M

Div yield —

Profitability & returns

ROE —

Net margin -129.0%

FCF margin -16.1%

Debt / equity —

Trading information

Last price $9.51

Day range $9.31 – $9.59

52-wk range $5.00 – $10.99

Avg volume 0.5M

RSI (2) 38.5

Trend zone Neutral

52-week range · today's price

$5.00$10.99

Company

Sector Healthcare

Industry Biotechnology

Exchange NMS

Next earnings 2026-08-11

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1). Its lead …